Diagnosing SLE: How Clinical Chemistry Helps

Welcome to our exploration of laboratory testing in Systemic Lupus Erythematosus, or SLE.The diagnosis of SLE begins with comprehensive blood testing, which provides objective evidence of disease activity.The Antinuclear Antibody test, or ANA, is a crucial marker for SLE diagnosis. It's positive in ninety-eight percent of SLE patients.A Complete Blood Count often reveals several abnormalities in SLE patients.Two antibodies are highly specific for SLE diagnosis: anti-double stranded DNA antibodies and anti-Smith antibodies.Complement proteins C3 and C4 are crucial indicators of SLE disease activity.When SLE becomes active, complement levels typically drop as these proteins are consumed in the inflammatory process.Two key inflammatory markers help track disease activity: Erythrocyte Sedimentation Rate, or ESR, and C-Reactive Protein, or CRP.The ratio between ESR and CRP helps differentiate between SLE flares and infections. In SLE flares, ESR is typically elevated while CRP remains relatively low.Regular monitoring of complement levels and inflammatory markers helps clinicians track disease progression and adjust treatment as needed.In monitoring SLE, specific organ systems require targeted testing.Kidney function tests are crucial for detecting lupus nephritis. Key markers include creatinine, blood urea nitrogen, and glomerular filtration rate.Urinalysis provides additional information about kidney involvement, including protein levels and the presence of blood cells.Liver function tests help identify hepatic involvement in SLE.We monitor enzymes like ALT and AST, along with proteins like albumin and bilirubin.Anti-phospholipid antibody testing is crucial for assessing thrombosis risk.Positive results have important clinical implications that affect patient management.